Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preoperative Oral Itraconazole for Basal Cell Carcinoma with Cutaneous Fungal Infection
jRCTs031250702Recruiting
- Sponsor
- University of Tsukuba Hospital
- Start
- Feb 2026
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of itraconazole in basal cell carcinoma (BCC), cutaneous fungal infection, dermatophytosis and 1 more, sponsored by University of Tsukuba Hospital. Started Feb 2026; status: recruiting.
02
Drugs
itraconazole
03
Conditions
basal cell carcinoma (BCC)cutaneous fungal infectiondermatophytosiscutaneous candidiasis
Beyond the preview
Go deeper on jRCTs031250702.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031250702.